J&J Hid Talc Cancer Risk For Profit, Jury Told

Law360, Los Angeles (April 11, 2017, 9:27 PM EDT) -- Johnson & Johnson hid the cancer-causing nature of its talcum powder products to preserve “corporate image over human life,” counsel for a woman who developed ovarian tumors after using J&J’s products said during Tuesday opening statements in the fifth Missouri jury trial over J&J's talc.

Allen R. Smith Jr. of the Talc Litigation Group, representing plaintiff Lois Slemp, launched into his opening statement by drawing a link between the case and the broader connection between talc and ovarian cancer, telling the St. Louis jury that the case they are about to try has “far-reaching consequences and deals with life and death...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS